|
|||||
|
|
Clinical evaluation of efficacy,tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus |
|
| Abstract: | |
| Keywords: | direct‐acting antiviral agent genotype 1 hepatitis C nonstructural protein 5A pharmacokinetics |